Financials Biohit Oyj

Equities

BIOBV

FI0009005482

Office Equipment

Market Closed - Nasdaq Helsinki 12:00:00 2024-07-12 pm EDT 5-day change 1st Jan Change
2.08 EUR +0.48% Intraday chart for Biohit Oyj +0.97% +10.34%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 27.61 23.62 28.49 31.56 - -
Enterprise Value (EV) 1 27.61 23.62 21.68 23.16 21.56 31.56
P/E ratio -18.4 x 39.3 x 15.7 x 16 x 16 x 13.9 x
Yield - - - - - -
Capitalization / Revenue - - 2.17 x 2.06 x 1.81 x 1.6 x
EV / Revenue - - 1.65 x 1.51 x 1.24 x 1.6 x
EV / EBITDA - - 9.85 x 10.1 x 7.7 x 9.28 x
EV / FCF - - 33.1 x 6.43 x 13.5 x 18.6 x
FCF Yield - - 3.02% 15.5% 7.42% 5.39%
Price to Book - - 3.04 x 2.74 x 2.34 x -
Nbr of stocks (in thousands) 15,046 15,046 15,114 15,174 - -
Reference price 2 1.835 1.570 1.885 2.080 2.080 2.080
Announcement Date 2/16/22 2/15/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - - 13.1 15.3 17.4 19.7
EBITDA 1 - - 2.2 2.3 2.8 3.4
EBIT 1 - - 1.8 1.9 2.5 2.8
Operating Margin - - 13.74% 12.42% 14.37% 14.21%
Earnings before Tax (EBT) 1 - - 2.2 2.1 2.5 2.8
Net income 1 -1.5 0.6 1.9 1.9 2 2.3
Net margin - - 14.5% 12.42% 11.49% 11.68%
EPS 2 -0.1000 0.0400 0.1200 0.1300 0.1300 0.1500
Free Cash Flow 1 - - 0.654 3.6 1.6 1.7
FCF margin - - 4.99% 23.53% 9.2% 8.63%
FCF Conversion (EBITDA) - - 29.73% 156.52% 57.14% 50%
FCF Conversion (Net income) - - 34.42% 189.47% 80% 73.91%
Dividend per Share 2 - - - - - -
Announcement Date 2/16/22 2/15/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 6.5 6.6 7.6 7.7 8.6 8.8
EBITDA 1 1.7 0.5 1.2 1.1 1.3 1.2
EBIT 1 1.5 0.3 1 0.9 1.3 1.2
Operating Margin 23.08% 4.55% 13.16% 11.69% 15.12% 13.64%
Earnings before Tax (EBT) 1 1.7 0.5 1.1 1 1.3 1.2
Net income 1 1.4 0.5 1 0.9 1.3 1.2
Net margin 21.54% 7.58% 13.16% 11.69% 15.12% 13.64%
EPS 2 0.0900 0.0300 0.0600 0.0600 0.0900 0.0800
Dividend per Share - - - - - -
Announcement Date 8/9/23 2/14/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - - 6.81 8.4 10 -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - 0.65 3.6 1.6 1.7
ROE (net income / shareholders' equity) - - 21.9% 18.2% 15.8% -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - - 0.6200 0.7600 0.8900 -
Cash Flow per Share 2 - - 0.0600 0.2900 0.1600 -
Capex 1 - - 0.25 0.7 0.7 0.8
Capex / Sales - - 1.89% 4.58% 4.02% 4.06%
Announcement Date 2/16/22 2/15/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.08 EUR
Average target price
2.4 EUR
Spread / Average Target
+15.38%
Consensus